Samuel Thevasagayam | Deputy Director, Global Development
The Bill & Melinda Gates Foundation | United States

Samuel Thevasagayam, Deputy Director, Global Development, The Bill & Melinda Gates Foundation


DC Co-conference Day 3 April 5 @ 11:30

Panel:Alternatives to Antibiotics: Issues and opportunities from funders’ perspective

  • How to incentivise vet pharma companies to produce new veterinary products to reduce AMR resistance
  • Marketing the science and the costs associated with this
  • Statement of societal goals that the funding entity would like to accomplish
  • Political feasibility of incentive mechanisms (e.g., is a program that gives money to large pharma companies likely to be accepted by legislators?)
  • Economics of incentive mechanisms (e.g., which incentive ‘lever’ can be pushed for maximal effect?  What would unintended consequences of such incentives be?)

back to speakers